Increased competition can result in lower prices and better service, but two researchers from Singapore Management University have found that it can also lead to businesses engaging in practices which can be potential harmful ...
Aug 29, 2022
0
24
When the Food and Drug Administration approved the first drug for people with spinal muscular atrophy a year ago, clinicians finally had hope for improving the lives of patients with the rare debilitating muscular disease. ...
Dec 11, 2017
1
9
Global health has paid a deadly price for not using simple, low-cost blood pressure lowering drugs, statins and aspirin widely in the form of a single pill, also known as the polypill, say two leading cardiologists in a commentary ...
Oct 13, 2022
0
62
In recent weeks, many locations in the U.S. have been lifting indoor face mask requirements, despite less than 70 percent of the population being fully vaccinated against COVID-19 and less than 45 percent having received ...
Mar 9, 2022
1
114
Despite efforts by insurance companies and other payers to move toward compensating physicians based on the quality and value of care they provide, most physicians employed in group practices owned by health systems are paid ...
Jan 28, 2022
0
4
You decide to take a popular colon cancer screening test that can be performed at home, and it comes back positive. A follow-up colonoscopy is scheduled, but then you suddenly receive a large and unexpected medical bill.
Jun 28, 2021
0
2
Children with Autism Spectrum Disorders (ASD) require an array of specialized health care services. With these services come higher costs for parents and insurance providers. University of Missouri researchers compared costs ...
Jun 11, 2012
0
0
A new large, international study finds that the immunosuppressant drug mycophenolate mofetil is superior to azathioprine, an older immunosuppressant, as a maintenance therapy for lupus nephritis.
Nov 16, 2011
0
0
One-fourth of children under age 8 with autism spectrum disorder—most of them black or Hispanic—are not being diagnosed, which is critical for improving quality of life.
Jan 9, 2020
0
3
The Trump administration's proposal to require pharmaceutical companies to publish drug prices in TV ads is unlikely to help control drug prices, according to a study publishing Jan. 22 in JAMA Internal Medicine.
Jan 22, 2019
0
2
